Page 4 - Protein Sciences News Today

Several biotechs in Mass. are seeking to elbow their way into the lucrative market, which is currently dominated by Denmark’s Novo Nordisk, which makes Wegovy and Ozempic, and Eli Lilly, which produces Mounjaro.

These three lesser-known healthcare companies have strong growth potential.

Immunocore (NASDAQ:IMCR – Get Free Report) and Bio-Techne (NASDAQ:TECH – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings. Profitability This table compares Immunocore and Bio-Techne’s net margins, return […]

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is pleased to launch the new Maurice Chromeleon Driver Kit, which enables control of its Maurice™...

Bio-Techne Co. (NASDAQ:TECH – Get Free Report) has received an average rating of “Moderate Buy” from the nine research firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among […]

Sandler Capital Management lowered its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 50.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 84,285 shares of the biotechnology company’s stock after selling 86,995 shares during the period. Sandler Capital Management’s holdings in Bio-Techne […]

Element Capital Management LLC bought a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the 1st quarter, Holdings Channel.com reports. The fund bought 20,552 shares of the biotechnology company’s stock, valued at approximately $1,525,000. Several other hedge funds have also recently modified their holdings of TECH. Private Advisor Group LLC lifted its holdings […]

Element Capital Management LLC purchased a new stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 20,552 shares of the biotechnology company’s stock, valued at approximately $1,525,000. Several other large investors have […]

Bio-Techne (NASDAQ:TECH – Get Free Report) and Valneva (NASDAQ:VALN – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability. Profitability This table compares Bio-Techne and Valneva’s net margins, return […]

Bio-Techne (NASDAQ:TECH – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. A number of other equities research analysts also recently issued reports on the stock. William Blair began coverage on shares of Bio-Techne in a research note on Monday, August […]